Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.19 USD | -0.12% | +0.14% | +0.98% |
Business Summary
Number of employees: 1,554
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 561 | 100.0 % | 573 | 100.0 % | +2.07% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
63.4
%
| 377 | 67.1 % | 363 | 63.4 % | -3.61% |
Canada
23.8
%
| 130 | 23.2 % | 136 | 23.8 % | +4.75% |
Israel
8.1
%
| 48 | 8.5 % | 46 | 8.1 % | -3.70% |
Other
4.8
%
| 7 | 1.2 % | 28 | 4.8 % | +311.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 16-11-30 | |
William Coote
DFI | Director of Finance/CFO | 69 | 07-12-31 |
Richard Glaze
CTO | Chief Tech/Sci/R&D Officer | 58 | - |
Hagai Reingold
COO | Chief Operating Officer | - | 01-12-31 |
Avi Avramoff
CTO | Chief Tech/Sci/R&D Officer | 59 | 11-09-30 |
James Kedrowski
BRD | Director/Board Member | 72 | 10-09-30 |
David Kinzelberg
AUD | Comptroller/Controller/Auditor | - | - |
Erik Zwicker
LAW | General Counsel | 44 | 20-04-12 |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 16-11-30 |
Michele Visosky
HRO | Human Resources Officer | 58 | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Stein
BRD | Director/Board Member | 73 | 20-01-31 |
Chairman | 68 | 10-09-21 | |
Director/Board Member | 67 | 10-08-31 | |
Oded Sarig
BRD | Director/Board Member | 68 | 23-06-26 |
Chief Executive Officer | 54 | 16-11-30 | |
James Kedrowski
BRD | Director/Board Member | 72 | 10-09-30 |
Director/Board Member | 58 | 16-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 3,719 | 2,600 | 0 | 0 | 17.92 % |
Stock B | 1 | 45,116,262 | 8,086,818 ( 17.92 %) | 7,531,631 ( 16.69 %) |
Company contact information
Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
2624761, Haifa Bay
+972 4 847 5700
http://www.taro.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.98% | 1.59B | |
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- TARO Stock
- Company Taro Pharmaceutical Industries Ltd.